CClinicalTrials.gg
CompletedNCT04921800Updated May 9, 2025Results posted

Measuring Dysphagia After ACDF Surgery Through A Novel Wearable Sensor

An interventional study of Anterior Cervical Discectomy & Fusion and Application of ADAM mechanoacoustic skin sensor in Cervical Spine Fusion, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years to 88 Years. Per ClinicalTrials.gov, last updated 2025-05-09.

Sponsored by Northwestern University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years to 88 Years
Sex
All
01

Study summary

The purpose of this study is to assess the function and reliability of a noninvasive, skin-like electronic sensor. The investigators hypothesize that this skin sensor will address an unmet need to wirelessly and noninvasively monitor and characterize the recovery process in post-operative patients who have undergone anterior cervical discectomy and fusion (ACDF). Specifically, the investigators will validate the use of the sensor in this patient population through monitoring of key physiological signals in the recovery process, including heart rate, respiratory rate, swallow count, talking time, energy expenditure, neck specific motion, and body orientation.

Read the detailed description

Dysphagia, dysphonia, and loss of cervical range of motion (ROM) are common complications after anterior cervical spine surgery, specifically anterior cervical discectomy and fusion (ACDF). Despite their clinical importance, studies on the treatment and/or prevention of these complications are limited due to the lack of valid and reliable outcome measures. The majority of research is found in the otolaryngology literature and has focused on disease pathophysiology, diagnosis, and therapy.

Dysphagia and dysphonia are widely measured by patient self-reported questionnaires, including the MD Anderson Dysphasia Inventory and SWAL-QOL. However, these validated outcome tools are cumbersome to complete and, therefore, have not been widely accepted into clinical practice, including in postoperative ACDF patients. The Bazaz score, a subjective questionnaire that has not been validated in the literature, has also been used to evaluate dysphagia after ACDF. Assessment using the Bazaz score is based on clinical examination, with the surgeon listening to the patient's voice and documenting hoarseness in the post-operative period. Recently, new patient-centered outcomes, the Eating Assessment Tool (EAT-10) and Voice Handicap Index (VHI-10) have been developed. Both EAT-10 and VHI-10 have excellent validity and reliability in evaluating dysphagia and dysphonia, respectively, in post-operative ACDF patients and can be used to document the initial dysphagia or dysphonia severity and monitor the treatment response in people with a wide array of swallowing and voice disorders. However, these methods of evaluating dysphagia and dysphonia alone offer limited information about the severity and characteristic of dysphagia or dysphonia and do not provide continuous monitoring of swallowing or speaking function throughout the post-operative period.

The wearable sensors under investigation in this study offer a novel, noninvasive, and easy-to-use way to monitor dysphagia, dysphonia, cervical ROM, and overall recovery progress in post-operative ACDF patients. Previous testing has demonstrated the ability of our sensors to monitor vital signs (including heart rate and respiratory rate), swallow count, talking time, energy expenditure, cervical neck movement, and body orientation. Sensor-measured swallow count and talking time, in conjunction with EAT-10 and VHI-10 scores, can provide a comprehensive view of the progression of dysphagia and dysphonia. Cervical neck movements measured by the sensor can enable continuous assessment of cervical ROM. Other general metrics captured by the sensors, including heart rate, respiratory rate, energy expenditure, and body orientation can provide other meaningful measures of recovery in post-operative ACDF patients. These sensors have also received positive feedback from patients and physicians on their comfort, ease of use, and application, further demonstrating the potential value of these sensors in improving the quality of post-operative care for ACDF patients.

02

Conditions studied

  • Cervical Spine Fusion

Keywords

  • cervical spine
  • fusion
  • discectomy
  • wearable technology
03

In context

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 88 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who have undergone anterior cervical discectomy and fusion (ACDF) for one or more levels for a diagnosis of cervical radiculopathy or myelopathy
  • Scheduled to return to the MSK orthopaedic clinic for a post-operative appointment
  • Aged between 18 to 88 years at time of surgery

Exclusion criteria

Exclusion Criteria:

  • Patients that underwent a revision of previous ACDF surgery at one or more operative levels
  • Surgeries performed for a traumatic or oncologic etiology
  • Members of vulnerable populations (i.e. prisoners, pregnant women)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Wearable Sensor Applied

    For these participants, the wearable ADAM sensor will be placed in the sternal notch to record anatomical data during the post-surgical period for up to 14 days

    Procedure: Anterior Cervical Discectomy & Fusion · Device: Application of ADAM mechanoacoustic skin sensor

Interventions

  • ProcedureAnterior Cervical Discectomy & Fusion

    Participants are undergoing previously scheduled anterior cervical discectomy \& fusion for single level or multiple level cervical disease

  • DeviceApplication of ADAM mechanoacoustic skin sensor

    Applying the ADAM sensor to the suprasternal notch following surgery to allow for collection of the anatomical data

06

What researchers measure

Primary outcomes

  1. Vibrational Frequency of Vocalization Following Surgery

    Sensitivity of the device to mechanoacoustic output from motion and vocalization in hertz (Hz)

    Time frame: 0 to 24 hours post operative

  2. Skin Temperature of the Surgical Site

    Sensitivity of the device to temperature of the surgical site in degrees Celsius

    Time frame: 0 to 24 hours post operative

  3. Muscular Force Generated During Range of Motion Exercises

    Force vectors measured in gravitational acceleration units (g; 9.81 meters per second squared)

    Time frame: 0 to 24 hours post operative

  4. Algorithm Validation

    Measuring the accuracy of the algorithm created to measure neck motion using the ADvanced Acousto-Mechanic sensor. Data analysis made no distinction between motion samples collected immediately after awaking from sedation in the post-anesthesia care unit and those collected immediately prior to discharge

    Time frame: Immediately after awaking from sedation in the post-anesthesia care unit and immediately prior to discharge

07

Results

Posted Apr 10, 2024
Limitations and caveats
The data collected by investigators did not match the a priori variables defined.

Participant flow

Participant flow — Overall Study
MilestoneWearable Sensor Applied
Started11
Completed11
Not completed0

Outcome measures

PrimaryVibrational Frequency of Vocalization Following Surgery

Sensitivity of the device to mechanoacoustic output from motion and vocalization in hertz (Hz)

Time frame:
0 to 24 hours post operative

No measurements were reported for this outcome.

PrimarySkin Temperature of the Surgical Site

Sensitivity of the device to temperature of the surgical site in degrees Celsius

Time frame:
0 to 24 hours post operative

No measurements were reported for this outcome.

PrimaryMuscular Force Generated During Range of Motion Exercises

Force vectors measured in gravitational acceleration units (g; 9.81 meters per second squared)

Time frame:
0 to 24 hours post operative

No measurements were reported for this outcome.

PrimaryAlgorithm Validation

Measuring the accuracy of the algorithm created to measure neck motion using the ADvanced Acousto-Mechanic sensor. Data analysis made no distinction between motion samples collected immediately after awaking from sedation in the post-anesthesia care unit and those collected immediately prior to discharge

Time frame:
Immediately after awaking from sedation in the post-anesthesia care unit and immediately prior to discharge
Reported as:
Mean · percentage of correct motions detected
Algorithm Validation
percentage of correct motions detectedWearable Sensor Applied
Algorithm Validation67.5 ± 5.8

Adverse events

Collected over 2 weeks postoperative. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wearable Sensor Applied0/11 (0%)0/11 (0%)5/11 (45.5%)
Most frequent other events
Most frequent other events
EventWearable Sensor Applied
PainMusculoskeletal and connective tissue disorders5/11

Baseline characteristics

Age, Continuous
Age, Continuous(years)Wearable Sensor Applied
Mean57 ± 11
Sex: Female, Male
Sex: Female, Male(Participants)Wearable Sensor Applied
Female7
Male4
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Wearable Sensor Applied
Region of Enrollment
Region of Enrollment(participants)Wearable Sensor Applied
United States11
08

Study locations

1 site
  • Northwestern Memorial Hospital
    Chicago, Illinois 60611, United States
09

References and documents

Study documents

  • Study protocol · Feb 22, 2021
  • Informed consent form · Feb 22, 2021

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04921800
Lead sponsor
Northwestern University
Responsible party
Sponsor
First posted
Jun 10, 2021
Start date
Mar 15, 2021
Primary completion
Dec 23, 2021
Completion
Sep 2, 2024
Results posted
Apr 10, 2024
Last update
May 9, 2025

Study contacts

Shuai Xu, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion